Loading...
Uploaded by MedPageToday on Oct 4, 2011
LISBON -- Whispered concerns about a higher risk of certain cancers linked with incretin therapies for diabetes have become more audible after a debate here between top researchers.
News & Politics
Standard YouTube License
Load more suggestions
Link to this comment:
All Comments (0)